Menu

Topics

Connect

Comments

Want to discuss? Please read our Commenting Policy first.

Vancouver Canucks acquire Russian forward from New York Rangers

The Vancouver Canucks acquired forward Vitali Kravtsov from the New York Rangers on Saturday in exchange for forward Will Lockwood and a seventh-round pick in the 2026 NHL Draft.

Story continues below advertisement

Kravtsov, 23, has six points (3 goals, 3 assists) in 28 games this season. The 6-foot-3 right winger was selected in the first round, ninth overall, in the 2018 draft.

“We are excited to add Vitali’s combination of size and skill to our group,” Canucks general manager Patrik Allvin said in a release. “He is a smart player and a former first-round pick with a good set of skills.

“We look forward to welcoming him to Vancouver to continue developing his game with our coaching staff.”

In his first NHL season, 2020-21, Kravtsov had 2 goals and 2 assists for 4 points in 20 games. He spent last season in the KHL with Chelyabinsk Traktor, earning 13 points (6 goals, 7 assists) in 19 games.

The daily email you need for BC's top news stories.
Story continues below advertisement

Lockwood, 24, has split this season between Vancouver and AHL Abbotsford. He has one assist in 13 NHL games and 18 points (12 goals, 6 assists) in 26 AHL games.

Also Saturday, the Canucks placed forward Curtis Lazar on injured reserve.

In related news, the Associated Press is reporting that by trading Kravtsov, the Rangers are gearing up to acquire Patrick Kane from the Chicago Blackhawks.

New York also put forward Jake Leschyshyn on waivers on Saturday, which could clear the cap space to get Kane, who is an impending free agent.

Story continues below advertisement

The Blackhawks are holding Kane out of their game at San Jose in preparation for a trade.

New York received Lockwood and the draft pick for Kravtsov in what’s essentially a salary dump.

More will come off the cap on Sunday when Leschyshyn is either claimed by another team or clears waivers and is sent to the minors.

 

Advertisement
Advertisement

You are viewing an Accelerated Mobile Webpage.

View Original Article